Ebola Vaccine Market

1.Executive Summary

2.Introduction
   2.1.Study Objectives
   2.2.Market Definition
         2.2.1. Market Covered
         2.2.2.Geographical Coverage
         2.2.3.Study Years & Currency
   2.3.Market Stakeholders
   2.4.Key Questions this Study will Answer
   2.5.GMI Research’s Approach & Methodology

3.Global Ebola Vaccine Market - Overview
   3.1.Introduction
   3.2.Market Segmentation
   3.3.Value Chain Analysis
   3.4.Drivers
   3.5.Restraints
   3.6.Trends

4.Global Ebola Vaccine Market Revenue Forecast till 2026

5.Global Ebola Vaccine Market by Virus Strain Revenue Forecast till 2026
   5.1.Chimpanzee Adeno virus type 3-Zaire Ebola virus
   5.2.Recombinant vesicular stomatitis virus-Zaire Ebola virus
   5.3.Adeno virus serotype 26- Zaire Ebola Virus

6.Global Ebola Vaccine Market by Geography Revenue Forecast till 2026
   6.1.North America Ebola Vaccine Market Revenue Forecast till 2026(Option 1: 25% customization)
         6.1.1.North America Ebola Vaccine Market by Virus Strain
                  6.1.1.1.15- Chimpanzee Adeno virus type 3-Zaire Ebola virus
                  6.1.1.2.Recombinant vesicular stomatitis virus-Zaire Ebola virus
                  6.1.1.3.Adeno virus serotype 26- Zaire Ebola Virus
   6.2.Europe Ebola Vaccine Market Revenue Forecast till 2026 (Option 2: 25% customization)
         6.2.1.Europe Ebola Vaccine Market by Virus Strain
                     6.2.1.1.15- Chimpanzee Adeno virus type 3-Zaire Ebola virus
                     6.2.1.2.Recombinant vesicular stomatitis virus-Zaire Ebola virus
                     6.2.1.3.Adeno virus serotype 26- Zaire Ebola Virus
   6.3.Asia-Pacific Ebola Vaccine Market Revenue Forecast till 2026(Option 3: 25% customization)
         6.3.1.Asia-Pacific Ebola Vaccine Market by Virus Strain
                     6.3.1.1.15- Chimpanzee Adeno virus type 3-Zaire Ebola virus
                     6.3.1.2.Recombinant vesicular stomatitis virus-Zaire Ebola virus
                     6.3.1.3.Adeno virus serotype 26- Zaire Ebola Virus
   6.4.Rest of the world Ebola Vaccine Market Revenue Forecast till 2026 (Option 4: 25% customization)
         6.4.1.Rest of the world Ebola Vaccine Market by Virus Strain
                     6.4.1.1.15- Chimpanzee Adeno virus type 3-Zaire Ebola virus
                     6.4.1.2.Recombinant vesicular stomatitis virus-Zaire Ebola virus
                     6.4.1.3.Adeno virus serotype 26- Zaire Ebola Virus

7.Competitive Landscape
   7.1.Market Structure
   7.2.Porter 5 Analysis
   7.3.Company Share Analysis

8.Company Profiles (Option 5: 25% Customization - Profiles of 5 Additional Companies of your Choice)
   8.1.Sarepta Therapeutics Inc.
         8.1.1.Company Overview
         8.1.2.Financials
         8.1.3.Recent Developments
   8.2.Mapp Biopharmaceutical Inc.
         8.2.1.Company Overview
         8.2.2.Financials
         8.2.3.Recent Developments
   8.3.Regeneron Pharmaceuticals, Inc.
         8.3.1.Company Overview
         8.3.2.Financials
         8.3.3.Recent Developments
   8.4.Merck & Company, Inc.
         8.4.1.Company Overview
         8.4.2.Financials
         8.4.3.Recent Developments
   8.5.GlaxoSmithKline plc.
         8.5.1.Company Overview
         8.5.2.Financials
         8.5.3.Recent Developments
   8.6. Novavax Inc.
         8.6.1.Company Overview
         8.6.2.Financials
         8.6.3.Recent Developments
   8.7.GeoVax Labs Inc.
         8.7.1.Company Overview
         8.7.2.Financials
         8.7.3.Recent Developments

9.About GMI Research

*Details on Financials might not be available in case of unlisted/private companies.
*The list of companies is based on preliminary research in this report, the companies in the final report may change based on research findings.